首页> Journal of gastrointestinal oncology> Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.

Patient-specific meta-analysis of 12-gene colon cancer recurrence score validation studies for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.

导出 OA

翻译打印收藏纠错

第一作者： Greg,Yothers

第一单位： NSABP, NRG Oncology, University of Pittsburgh, Pittsburgh, PA, USA.

作者： Greg,Yothers ^[1] ; Alan P,Venook ^[2] ; Eiji,Oki ^[3] ; Donna,Niedzwiecki ^[4] ; Yan,Lin ^[1] ; Michael R,Crager ^[5] ; Calvin,Chao ^[6] ; Frederick L,Baehner ^[7] ; Norman,Wolmark ^[1] ; Takayuki,Yoshino ^[8]

作者单位： NSABP, NRG Oncology, University of Pittsburgh, Pittsburgh, PA, USA. ^[1] Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA. ^[2] Department of Surgery and Science, Kyushu University, Kyushu, Japan. ^[3] Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. ^[4] Department of Biostatistics, Precision Oncology, Exact Sciences Corporation, Redwood City, CA, USA. ^[5] Global Medical Affairs, Precision Oncology, Exact Sciences Corporation, Redwood City, CA, USA. ^[6] Helen Diller Family Comprehensive Cancer Center, University of California at San Francisco, San Francisco, CA, USA.;Medical Department, Precision Oncology, Exact Sciences Corporation, Redwood City, CA, USA. ^[7] National Cancer Center Hospital East, Kashiwa, Japan. ^[8]

关键词 12-gene assay Colon cancer meta-analysis recurrence risk

DOI 10.21037/jgo-21-620

PMID 35284101

发布时间 2022-03-15

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交